Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dysplastic Nevus Syndrome × Betulinic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Dysplastic Nevus Syndrome 1

Interventions

Dermoscopy 2 pembrolizumab 1 Transdermal Patch 1 Sutures 1 Standard of Care 1 Secretin 1 Practice Guidelines as Topic 1 Pharmaceutical Preparations 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Genome 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Diagnostic Imaging 1 Data Collection 1 CA-19-9 Antigen 1 Betulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00346502 2021-06-28

Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia)

University of Illinois at Chicago

Phase 1/2 Withdrawn

Dysplastic Nevus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡